dibase 2.000 i.j. 2000 i.j./1 kapsula kapsula, tvrda
amicus pharma d.o.o. - holekalciferol - kapsula, tvrda - 2000 i.j./1 kapsula - jedna kapsula, tvrda sadrži: 0,050 mg holekalciferola (vitamin d3), što odgovara 2000 i.j.
dibase 6.000 i.j. 6000 i.j./1 kapsula kapsula, tvrda
amicus pharma d.o.o. - holekalciferol - kapsula, tvrda - 6000 i.j./1 kapsula - jedna kapsula, tvrda sadrži 0,150 mg holekalciferola (vitamin d3), što odgovara 6000 i.j.
dibase 25.000 i.j 25000 i.j./1 kapsula kapsula, tvrda
amicus pharma d.o.o. - holekalciferol - kapsula, tvrda - 25000 i.j./1 kapsula - jedna kapsula, tvrda sadrži 0,625 mg holekalciferola (vitamin d3), što odgovara 25.000 i.j.
dibase 1.000 i.j. 1000 i.j./1 kapsula kapsula, tvrda
amicus pharma d.o.o. - holekalciferol - kapsula, tvrda - 1000 i.j./1 kapsula - jedna kapsula, tvrda sadrži 0,025 mg holekalciferola (vitamin d3), što odgovara 1000 i.j.
nimulid 100 mg/1 tableta tableta
amicus pharma d.o.o. - nimesulid - tableta - 100 mg/1 tableta - 1 tableta sadrži: 100 mg nimesulid
nimulid transgel 10 mg/1 g gel
amicus pharma d.o.o. - nimesulid - gel - 10 mg/1 g - 1 g gela sadrži: 10 mg nimesulid
nimulid md 100 mg/1 tableta oralna disperzibilna tableta
amicus pharma d.o.o. - nimesulid - oralna disperzibilna tableta - 100 mg/1 tableta - 1 oralna disperzibilna tableta sadrži: 100 mg nimesulida
nimulid 100 mg/1 tableta tableta
amicus pharma d.o.o. - nimesulid - tableta - 100 mg/1 tableta - 1 tableta sadrži: 100 mg nimesulida
nimulid transgel 10 mg/1 g gel
amicus pharma d.o.o. - nimesulid - gel - 10 mg/1 g - 1 g gela sadrži: 10 mg nimesulid
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.